首页|期刊导航|广州医药|肠道支架治疗梗阻性结直肠癌的治疗现状

肠道支架治疗梗阻性结直肠癌的治疗现状OA

Current status of intestinal stent therapy for obstructive colorectal cancer

中文摘要英文摘要

约10%~30%的新发结直肠癌患者会出现急性肠梗阻,传统急诊手术治疗存在术后并发症高、死亡率高、生存质量低等不足.肠道支架置入联合限期手术作为一种新型治疗策略,展现出显著优势.肠道支架可迅速解除梗阻,改善患者症状,降低手术风险,为肿瘤微创切除创造条件,同时为新辅助化疗提供可能,但其潜在并发症如出血、移位、再梗阻及肠穿孔等也不容忽视,且长期安全性及对肿瘤结局的影响尚不明确.文章综述了肠道支架治疗梗阻性结直肠癌的治疗现状、争议及研究进展,旨在为临床研究和实践提供参考依据.

Approximately 10%to 30%of patients with newly diagnosed colorectal cancer present with acute intestinal obstruction.Traditional emergency surgical intervention is characterized by high rates of postoperative complications,elevated mortality,and diminished quality of life.Combined stent and curative elective surgery(CSCES)has emerged as a novel therapeutic strategy,exhibiting significant clinical benefits.Intestinal stenting can rapidly alleviate obstruction,thereby improving patient symptoms,reducing surgical risks,and facilitating minimally invasive tumor resection.Additionally,it provides an opportunity for neoadjuvant chemotherapy.However,potential complications,including bleeding,stent migration,recurrent obstruction,and intestinal perforation,must be carefully considered.Moreover,the long-term safety and impact on oncologic outcomes remain to be elucidated.This review aims to provide a comprehensive overview of the current status,controversies,and recent advancements in the use of intestinal stents for the treatment of obstructive colorectal cancer,with the goal of informing clinical research and practice.

丁国盛;李旺林

广州市花都医学研究所,广州市花都区人民医院(广东 广州 510800)广州市花都医学研究所,广州市花都区人民医院(广东 广州 510800)

肠道支架梗阻性结直肠癌肠道支架置入联合限期手术治疗现状

intestinal stentobstructive colorectal cancercombined stent and curative elective surgerycurrent treatment status

《广州医药》 2026 (4)

396-401,412,7

广东省粤桂联合基金重点项目(2021B1515420004)广州市基础研究计划市校(院)企联合资助专题项目(2025A03J4164)广州市高新技术专项项目(SYCZZX242518)广西肿瘤免疫与微环境调控重点实验室开放课题资助(KF202501)

10.20223/j.cnki.1000-8535.2026.04.001

评论